Articles avec mandats d'accès public - Evan BlochEn savoir plus
Non disponibles : 8
Bacterial contamination of blood products in Africa
Y Ahmad, AS Heroes, HA Hume, M Farouk, A Owusu‐Ofori, EA Gehrie, ...
Transfusion 61 (3), 767-780, 2021
Exigences : US National Institutes of Health, Research Foundation (Flanders)
Blood transfusion safety in low-resourced countries: aspiring to a higher standard
EM Bloch, EA Gehrie, PM Ness, J Sugarman, AAAR Tobian
Annals of internal medicine 173 (6), 482-483, 2020
Exigences : US National Institutes of Health
Climate change and parasitic risk to the blood supply
SJ Drews, S Wendel, DA Leiby, L Tonnetti, I Ushiro‐Lumb, SF O'Brien, ...
Transfusion 63 (3), 638-645, 2023
Exigences : US National Institutes of Health
Microchimerism in the transfused obstetric population
EM Bloch, MP Busch, TH Lee, L Montalvo, Y Matthews, A Bird, R Bruhn, ...
Vox sanguinis 107 (4), 428-430, 2014
Exigences : US National Institutes of Health
Euvolemic automated transfusion to treat severe anemia in sickle cell disease patients at risk of circulatory overload
N Mercure‐Corriveau, EP Crowe, S Vozniak, X Feng, H Rai, ...
Transfusion 64 (1), 124-131, 2024
Exigences : US National Institutes of Health, Patient-Centered Outcomes Research Institute
Bacterial contamination of blood components
EM Bloch, RJ Benjamin, S Ramirez‐Arcos
Rossi's Principles of Transfusion Medicine, 533-542, 2022
Exigences : US National Institutes of Health
Powassan virus: What is the risk to the blood supply?
EM Bloch, AAR Tobian, LM Katz
Transfusion 61 (12), 3286-3288, 2021
Exigences : US National Institutes of Health
Algorithm‐based selection of automated red blood cell exchange procedure goals reduces blood utilization in chronically transfused adults with sickle cell disease
KR Buban, CE Lawrence, XJ Zhu, AAR Tobian, EA Gehrie, S Vozniak, ...
Journal of Clinical Apheresis 37 (5), 468-475, 2022
Exigences : US National Institutes of Health
Disponibles quelque part : 145
Deployment of convalescent plasma for the prevention and treatment of COVID-19
EM Bloch, S Shoham, A Casadevall, BS Sachais, B Shaz, JL Winters, ...
The Journal of clinical investigation 130 (6), 2757-2765, 2020
Exigences : US National Institutes of Health
Sex, age, and hospitalization drive antibody responses in a COVID-19 convalescent plasma donor population
SL Klein, A Pekosz, HS Park, RL Ursin, JR Shapiro, SE Benner, ...
The Journal of clinical investigation 130 (11), 6141-6150, 2020
Exigences : US Department of Defense, US National Institutes of Health
Early outpatient treatment for Covid-19 with convalescent plasma
DJ Sullivan, KA Gebo, S Shoham, EM Bloch, B Lau, AG Shenoy, ...
New England Journal of Medicine 386 (18), 1700-1711, 2022
Exigences : US Department of Defense, US National Institutes of Health
SARS-CoV-2–specific CD8+ T cell responses in convalescent COVID-19 individuals
H Kared, AD Redd, EM Bloch, TS Bonny, H Sumatoh, F Kairi, D Carbajo, ...
The Journal of clinical investigation 131 (5), 2021
Exigences : US Department of Defense, US National Institutes of Health
Blood transfusion safety in Africa: a literature review of infectious disease and organizational challenges
EM Bloch, M Vermeulen, E Murphy
Transfusion medicine reviews 26 (2), 164-180, 2012
Exigences : US National Institutes of Health
Comparative performance of five commercially available serologic assays to detect antibodies to SARS-CoV-2 and identify individuals with high neutralizing titers
EU Patel, EM Bloch, W Clarke, YH Hsieh, D Boon, Y Eby, RE Fernandez, ...
Journal of Clinical Microbiology 59 (2), 10.1128/jcm. 02257-20, 2021
Exigences : US Department of Defense, US National Institutes of Health
ABO blood group and COVID‐19: a review on behalf of the ISBT COVID‐19 working group
R Goel, EM Bloch, F Pirenne, AZ Al‐Riyami, E Crowe, L Dau, K Land, ...
Vox sanguinis 116 (8), 849-861, 2021
Exigences : US National Institutes of Health
Metabolic programs define dysfunctional immune responses in severe COVID-19 patients
EA Thompson, K Cascino, AA Ordonez, W Zhou, A Vaghasia, ...
Cell reports 34 (11), 2021
Exigences : Bill & Melinda Gates Foundation, US National Institutes of Health
SARS-CoV-2 antibody avidity responses in COVID-19 patients and convalescent plasma donors
SE Benner, EU Patel, O Laeyendecker, A Pekosz, K Littlefield, Y Eby, ...
The Journal of infectious diseases 222 (12), 1974-1984, 2020
Exigences : US Department of Defense, US National Institutes of Health
Genomic epidemiology reconstructs the introduction and spread of Zika virus in Central America and Mexico
J Thézé, T Li, L Du Plessis, J Bouquet, MUG Kraemer, S Somasekar, G Yu, ...
Cell host & microbe 23 (6), 855-864. e7, 2018
Exigences : US National Institutes of Health, Wellcome Trust, European Commission
CD8+ T-cell responses in COVID-19 convalescent individuals target conserved epitopes from multiple prominent SARS-CoV-2 circulating variants
AD Redd, A Nardin, H Kared, EM Bloch, A Pekosz, O Laeyendecker, ...
Open Forum Infectious Diseases 8 (7), ofab143, 2021
Exigences : US National Institutes of Health
Minimal Crossover between Mutations Associated with Omicron Variant of SARS-CoV-2 and CD8+ T-Cell Epitopes Identified in COVID-19 Convalescent Individuals
AD Redd, A Nardin, H Kared, EM Bloch, B Abel, A Pekosz, ...
MBio 13 (2), e03617-21, 2022
Exigences : US National Institutes of Health
Les informations concernant la publication et le financement sont déterminées automatiquement par un programme informatique